Key regions: Canada, United Kingdom, United States, China, Europe
The Cold & Cough Remedies (Pharmacies) market in G7 is experiencing significant development and growth. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this positive trajectory. Customer preferences for Cold & Cough Remedies (Pharmacies) in the G7 countries are shifting towards natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived as safer and more effective. This preference for natural remedies is driving the demand for herbal ingredients and formulations in the Cold & Cough Remedies (Pharmacies) market. Trends in the market show a growing emphasis on product innovation and differentiation. Companies are investing in research and development to create new and improved Cold & Cough Remedies (Pharmacies) that address specific symptoms and provide targeted relief. This trend is driven by the increasing competition in the market and the need to stand out in a crowded marketplace. Local special circumstances in each G7 country also play a role in the development of the Cold & Cough Remedies (Pharmacies) market. For example, in the United States, the high prevalence of cold and flu during the winter season drives the demand for these remedies. In Japan, where the aging population is a significant demographic, there is a growing demand for Cold & Cough Remedies (Pharmacies) that cater to the specific needs of older adults. Underlying macroeconomic factors, such as population growth and healthcare expenditure, also contribute to the development of the Cold & Cough Remedies (Pharmacies) market in the G7 countries. As the population continues to grow and age, the demand for healthcare products, including Cold & Cough Remedies (Pharmacies), is expected to increase. Additionally, rising healthcare expenditure in these countries indicates a willingness to invest in preventive and curative healthcare, further driving the growth of the market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in the G7 countries is developing due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards natural remedies, focus on product innovation, and specific demographic needs are all contributing to the growth of this market. With the population growth and increasing healthcare expenditure, the demand for Cold & Cough Remedies (Pharmacies) is expected to continue to rise in the G7 countries.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
